Skip to main content

Research News

  • Like a dairy farmer tending to a herd of cows to produce milk, researchers are tending to colonies of the bacteria Escherichia coli (E. coli) to produce new forms of antibiotics — including three that show promise in fighting drug-resistant bacteria.

  • An international team including scientists from Albert Einstein College of Medicine of Yeshiva University and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells. The findings, made in mice, suggest that drugs blocking entry to this lock could protect against Ebola infection.

  • The humble onion is proving its strength outside the culinary world, enabling scientists to develop artificial muscles by using gold-plated cells of the vegetable. Unlike previous artificial muscles, this one, created by a group of researchers from National Taiwan University, can either expand or contract to bend in different directions depending on the driving voltage applied.

  • An autonomous body under the AYUSH department of Union Health Ministry is planning to tieup with top homeopathy research organisations with an aim of boosting the healthcare industry. The Central Council for Research in Homeopathy (CCRH), the autonomous body under AYUSH, has called for further research to promote this system of medicine, said Dr R K Manchanda, Director General of CCRH.

  • India and Canada will partner in health innovations in India focussing on maternal, newborn and child health and Visceral Leishmaniasis elimination and will make an invest of US dollar 2.5 million. The Department of Biotechnology (DBT) and Grand Challenges Canada (GCC), funded by the Government of Canada, will work to eliminate Visceral Leishmaniasis (VL, Kala Azar) in Bihar.

  • The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, oste porosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. The candidate drugs are currently undergoing clinical trials, he said.

    [adsense:336x280:8701650588]

  • Stempeutics Research, a part of the Manipal Education and Medical Group (MEMG), has received process patent from the State Intellectual Property Office of China (SIPO) for its novel stem-cell based drug Stempeucel for the treatment of Critical Limb Ischemia (CLI), a progressive form of peripheral arterial disease.

  • Researchers studying the commonly used pain reliever acetaminophen or paracetamol have found that it has a previously unknown side effect: it blunts positive emotions. In the study, participants who took acetaminophen reported less strong emotions when they saw both very pleasant and very disturbing photos, when compared to those who took placebos.

  • Despite mutating, the ebola virus has not evolved to become deadlier since the first outbreak 40 years ago, scientists say. The findings suggest that the much higher death toll during the current outbreak, with the figure at nearly 10,500, is not due to mutations making the virus more deadly or more virulent.

Subscribe to Research News